Recovery of perfluorinated polyether oils from grease matrices incorporating extraction aids by carbon dioxide extraction
US-2016319216-A1 · Nov 3, 2016 · US
US2019153027A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2019153027-A1 |
| Application number | US-201916259489-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 28, 2019 |
| Priority date | Jun 16, 2014 |
| Publication date | May 23, 2019 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
In various embodiments, the present invention provides a process for separating target proteins from non-target proteins in a sample comprising increasing the concentration of the target proteins and non-target proteins in the sample and subsequently delivering the concentrated sample to a chromatography device. In other embodiments, the invention relates to a process for increasing the capacity of a chromatography device for a target protein by delivering a concentrated sample comprising the target protein to a chromatography device.
Opening claim text (preview).
What is claimed is: 1 . A process for purifying target proteins from non-target proteins and viruses in a liquid sample, comprising: a) increasing a concentration of target proteins, non-target proteins, and viruses in the sample by a single-pass tangential flow filtration (SPTFF) process to produce a concentrated feed; b) delivering the concentrated feed to an anion exchange (AEX) chromatography device; c) separating the target proteins from the non-target proteins and viruses in the AEX chromatography device; and d) recovering the target proteins from the AEX chromatography device. 2 . The process of claim 1 , further comprising diafiltering the liquid sample prior to increasing the concentration of target proteins and non-target proteins in the sample by the SPTFF process. 3 . The process of claim 2 , wherein diafiltering the liquid sample includes adding a diafiltration solution to the unfiltered sample at a same rate of removing permeate from the sample during the SPTFF process. 4 . The process of claim 1 , wherein the SPTFF process provides direct flow-through concentration of the liquid sample to the AEX device. 5 . The process of claim 1 , wherein the AEX chromatography device includes an Eshmuno® Q resin. 6 . The process of claim 1 , wherein the SPTFF process is an ultrafiltration SPTFF process. 7 . The process of claim 1 , wherein the target proteins are monoclonal antibodies. 8 . The process of claim 1 , wherein the non-target proteins are host cell proteins from hybridoma cells expressing the target protein. 9 . A process for purifying target proteins from non-target proteins in a liquid sample, comprising: a) increasing a concentration of target proteins and non-target proteins in the sample by a single-pass tangential flow filtration (SPTFF) process to produce a concentrated feed; b) delivering the concentrated feed to protein A chromatography device; c) separating the target proteins from the non-target proteins in the protein A chromatography device; and d) recovering the target proteins from the protein A chromatography device. 10 . The process of claim 9 , wherein the SPTFF process provides direct flow-through concentration of the liquid sample to the protein A chromatography device. 11 . The process of claim 9 , wherein the protein A chromatography device includes a protein A affinity resin. 12 . The process of claim 9 , wherein the protein A chromatography device includes a protein A affinity membrane. 13 . The process of claim 9 , wherein the target proteins are monoclonal antibodies. 14 . The process of claim 9 , wherein the non-target proteins are host cell proteins from hybridoma cells expressing the target protein.
Living organisms or biological materials · CPC title
Filtration · CPC title
Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title
by filtration, ultrafiltration or reverse osmosis · CPC title
Parts of membrane modules specifically adapted for single use · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.